| Jun 6 |
Sector Update: Health Care Stocks Higher in Late Afternoon Trading
|
| Jun 6 |
Vanda Pharma surges on $8 a share takeover offer from Cycle Pharma (update)
|
| Jun 6 |
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
|
| May 30 |
J&J transfers Ponvory FDA applications to Vanda, launch seen in Q3
|
| May 30 |
Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference
|
| May 30 |
Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®
|
| May 29 |
Vanda Pharmaceuticals Announces Presentations at SLEEP 2024
|
| May 24 |
Vanda Pharmaceuticals rejects sweetened bid from Future Pak
|
| May 24 |
Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders
|
